Connor, Clark & Lunn Investment Management Ltd. Quanterix Corp Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $20 Billion
- Q4 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Quanterix Corp stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 31,902 shares of QTRX stock, worth $239,903. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,902
Previous 38,550
17.25%
Holding current value
$239,903
Previous $499,000
32.06%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding QTRX
# of Institutions
163Shares Held
34.9MCall Options Held
121KPut Options Held
41K-
Ameriprise Financial Inc Minneapolis, MN3.21MShares$24.1 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.14MShares$23.6 Million0.0% of portfolio
-
Portolan Capital Management, LLC Boston, MA2.59MShares$19.5 Million2.08% of portfolio
-
Alliancebernstein L.P. New York, NY2.44MShares$18.3 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.22MShares$16.7 Million0.0% of portfolio
About Quanterix Corp
- Ticker QTRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 36,987,600
- Market Cap $278M
- Description
- Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...